Literature DB >> 15271947

Aeromonas hydrophila beta-hemolysin induces active chloride secretion in colon epithelial cells (HT-29/B6).

H J Epple1, J Mankertz, R Ignatius, O Liesenfeld, M Fromm, M Zeitz, T Chakraborty, J D Schulzke.   

Abstract

The diarrheal mechanisms in Aeromonas enteritis are not completely understood. In this study we investigated the effect of aeromonads and of their secretory products on ion secretion and barrier function of monolayers of human intestinal cells (HT-29/B6). Ion secretion was determined as a short-circuit current (I(SC)) of HT-29/B6 monolayers mounted in Ussing-type chambers. Transepithelial resistance (R(t)) served as a measure of permeability. A diarrheal strain of Aeromonas hydrophila (strain Sb) added to the mucosal side of HT-29/B6 monolayers induced a significant I(SC) (39 +/- 3 microA/cm(2)) and decreased the R(t) to approximately 10% of the initial value. A qualitatively identical response was obtained with sterile supernatant of strain Sb, and Aeromonas supernatant also induced a significant I(SC) in totally stripped human colon. Tracer flux and ion replacement studies revealed the I(SC) to be mainly accounted for by electrogenic Cl(-) secretion. Supernatant applied serosally completely abolished basal I(SC). The supernatant-induced I(SC) was inhibited by the protein kinase C inhibitor chelerythrine, whereas a protein kinase A inhibitor (H8) and a Ca(2+) chelator (BAPTA-AM) had no effect. Physicochemical properties indicated that the supernatant's active compound was an aerolysin-related Aeromonas beta-hemolysin. Accordingly, identical I(SC) and R(t) responses were obtained with Escherichia coli lysates harboring the cloned beta-hemolysin gene from strain SB or the aerA gene encoding for aerolysin. Sequence comparison revealed a 64% homology between aerolysin and the beta-hemolysin cloned from Aeromonas sp. strain Sb. In conclusion, beta-hemolysin secreted by pathogenic aeromonads induces active Cl(-) secretion in the intestinal epithelium, possibly by channel insertion into the apical membrane and by activation of protein kinase C.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271947      PMCID: PMC470692          DOI: 10.1128/IAI.72.8.4848-4858.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  Enterotoxins in Aeromonas-associated gastroenteritis.

Authors:  A K Chopra; C W Houston
Journal:  Microbes Infect       Date:  1999-11       Impact factor: 2.700

Review 2.  Not as simple as just punching a hole.

Authors:  M Fivaz; L Abrami; Y Tsitrin; F G van der Goot
Journal:  Toxicon       Date:  2001-11       Impact factor: 3.033

3.  Studies of the mechanism of action of the aerolysin-like hemolysin of Aeromonas sobria in stimulating T84 cells to produce cyclic AMP.

Authors:  Yoshio Fujii; Tomohiko Nomura; Ritsuko Yokoyama; Sumio Shinoda; Keinosuke Okamoto
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

4.  Antisecretory effect of loperamide in colon epithelial cells by inhibition of basolateral K+ conductance.

Authors:  H J Epple; M Fromm; E O Riecken; J D Schulzke
Journal:  Scand J Gastroenterol       Date:  2001-07       Impact factor: 2.423

5.  Channels formed by subnanomolar concentrations of the toxin aerolysin trigger apoptosis of T lymphomas.

Authors:  K L Nelson; R A Brodsky; J T Buckley
Journal:  Cell Microbiol       Date:  1999-07       Impact factor: 3.715

6.  Partial characterization of aerolysin, a lytic exotoxin from Aeromonas hydrophila.

Authors:  A W Bernheimer; L S Avigad
Journal:  Infect Immun       Date:  1974-06       Impact factor: 3.441

Review 7.  Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects.

Authors:  K E Barrett; S J Keely
Journal:  Annu Rev Physiol       Date:  2000       Impact factor: 19.318

8.  Sensitivity of polarized epithelial cells to the pore-forming toxin aerolysin.

Authors:  Laurence Abrami; Marc Fivaz; Pierre-Etienne Glauser; Nakaba Sugimoto; Chiara Zurzolo; F Gisou van der Goot
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

9.  Adhesion to and invasion of human colon carcinoma Caco-2 cells by Aeromonas strains.

Authors:  Y Nishikawa; A Hase; J Ogawasara; S M Scotland; H R Smith; T Kimura
Journal:  J Med Microbiol       Date:  1994-01       Impact factor: 2.472

10.  Polarized signaling via purinoceptors in normal and cystic fibrosis airway epithelia.

Authors:  A M Paradiso; C M Ribeiro; R C Boucher
Journal:  J Gen Physiol       Date:  2001-01       Impact factor: 4.086

View more
  5 in total

1.  Listeria monocytogenes exploits cystic fibrosis transmembrane conductance regulator (CFTR) to escape the phagosome.

Authors:  Andrea L Radtke; Kelsi L Anderson; Michael J Davis; Matthew J DiMagno; Joel A Swanson; Mary X O'Riordan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

2.  Microarray and proteomics analyses of human intestinal epithelial cells treated with the Aeromonas hydrophila cytotoxic enterotoxin.

Authors:  C L Galindo; A A Fadl; Jian Sha; L Pillai; C Gutierrez; A K Chopra
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

3.  Diarrheal Mechanisms and the Role of Intestinal Barrier Dysfunction in Campylobacter Infections.

Authors:  Fábia Daniela Lobo de Sá; Jörg-Dieter Schulzke; Roland Bücker
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

4.  Zinc treatment is efficient against Escherichia coli α-haemolysin-induced intestinal leakage in mice.

Authors:  Stephanie Wiegand; Silke S Zakrzewski; Miriam Eichner; Emanuel Schulz; Dorothee Günzel; Robert Pieper; Rita Rosenthal; Christian Barmeyer; André Bleich; Ulrich Dobrindt; Jörg-Dieter Schulzke; Roland Bücker
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

5.  Immune Response of the Monocytic Cell Line THP-1 Against Six Aeromonas spp.

Authors:  Ana Fernández-Bravo; Maria José Figueras
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.